You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

MAGNEVIST Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Magnevist patents expire, and what generic alternatives are available?

Magnevist is a drug marketed by Bayer Hlthcare and is included in two NDAs.

The generic ingredient in MAGNEVIST is gadopentetate dimeglumine. There is one drug master file entry for this compound. Additional details are available on the gadopentetate dimeglumine profile page.

Summary for MAGNEVIST
Drug patent expirations by year for MAGNEVIST
Drug Prices for MAGNEVIST

See drug prices for MAGNEVIST

Recent Clinical Trials for MAGNEVIST

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Dipan ShahN/A
GuerbetN/A
Patricia Kim Phuong NguyenPhase 4

See all MAGNEVIST clinical trials

US Patents and Regulatory Information for MAGNEVIST

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare MAGNEVIST gadopentetate dimeglumine INJECTABLE;INJECTION 019596-001 Jun 2, 1988 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Bayer Hlthcare MAGNEVIST gadopentetate dimeglumine INJECTABLE;INJECTION 021037-001 Mar 10, 2000 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MAGNEVIST

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare MAGNEVIST gadopentetate dimeglumine INJECTABLE;INJECTION 019596-001 Jun 2, 1988 ⤷  Try a Trial ⤷  Try a Trial
Bayer Hlthcare MAGNEVIST gadopentetate dimeglumine INJECTABLE;INJECTION 021037-001 Mar 10, 2000 ⤷  Try a Trial ⤷  Try a Trial
Bayer Hlthcare MAGNEVIST gadopentetate dimeglumine INJECTABLE;INJECTION 021037-001 Mar 10, 2000 ⤷  Try a Trial ⤷  Try a Trial
Bayer Hlthcare MAGNEVIST gadopentetate dimeglumine INJECTABLE;INJECTION 021037-001 Mar 10, 2000 ⤷  Try a Trial ⤷  Try a Trial
Bayer Hlthcare MAGNEVIST gadopentetate dimeglumine INJECTABLE;INJECTION 021037-001 Mar 10, 2000 ⤷  Try a Trial ⤷  Try a Trial
Bayer Hlthcare MAGNEVIST gadopentetate dimeglumine INJECTABLE;INJECTION 019596-001 Jun 2, 1988 ⤷  Try a Trial ⤷  Try a Trial
Bayer Hlthcare MAGNEVIST gadopentetate dimeglumine INJECTABLE;INJECTION 019596-001 Jun 2, 1988 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for MAGNEVIST

See the table below for patents covering MAGNEVIST around the world.

Country Patent Number Title Estimated Expiration
Sweden 512863 Diagnostisk komposition innehållande minst ett fysiologiskt fördragbart komplexsalt ⤷  Try a Trial
Denmark 89794 ⤷  Try a Trial
Netherlands 9900020 ⤷  Try a Trial
Denmark 170460 ⤷  Try a Trial
Sweden 510582 Diagnostiska medel innehållande minst ett fysiologiskt fördragbart komplexsalt av anjonen av en komplexbildande syra ⤷  Try a Trial
Netherlands 195071 ⤷  Try a Trial
United Kingdom 8529903 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.